| HOME >> MEDICINE >> TECHNOLOGY |
(a)1,0221,021
(a)(a) - (l) See explanatory notes on the following pages. Amgen Inc.Condensed Consolidated Statements of Income andReconciliation of GAAP Earnings to "Adjusted" Earnings (In millions, except per share data)(Unaudited)Nine months endedNine months endedSeptember 30, 2010September 30, 2009GAAPAdjustments
"Adjusted"GAAPAdjustments
"Adjusted"Revenues:Product sales$ 10,900$
-$ 10,900$ 10,608$
-$ 10,608Other revenues312-312225-225Total revenues11,212-11,21210,833-10,833Cost of sales (excludes amortization of certainacquired intangible assets presented below)1,648(11)
(a)1,6371,553(9)
(a)1,543(1)
(f)Research and development2,040(40)
(a)1,9481,973(40)
(a)1,875(52)
(b)(52)
(b)(6)
(f)Selling, general and administrative2,827(44)
(a)2,7832,640(39)
(a)2,578(23)
(f)Amortization of certain acquired intangible assets221(221)
(c)-221(221)
(c)-Other (1)1
(e)-63(28)
(e)-(35)
(f)Total operating expenses6,735(367)6,3686,450(454)5,996Operating income4,4773674,8444,3834544,837Interest expense, net442(198)
(d)244436(186)
(d)250Interest and other income, net283-283182-182Income before income taxes4,3185654,8834,1296404,769Provision for income taxes713211
(g)962455235
(h)82038
(i)87
(i)25
(j)18
(k)Net income $ 3,605$ 316$
3,921$ 3,674$ 275$
3,949Earnings per share:Basic $
3.73$
4.06$
3.60$
3.87Diluted (l)$
3.71$
4.04
(a)$
3.58$
3.86
(a)Average shares used in calculationof earnings per share:Basic 9669661,0201,020Diluted (l)971971
(a)1,0251,024
(a)(a) - (l) See explanato
'/>"/>
| SOURCE Amgen Copyright©2010 PR Newswire. All rights reserved |